# FDA 483 - Hemacare Corp - September 18, 2008

Source: https://www.globalkeysolutions.net/records/483/hemacare-corp/376ef26b-babb-4ef4-b163-fea39a78def1

> FDA 483 for Hemacare Corp on September 18, 2008. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Hemacare Corp
- Inspection Date: 2008-09-18
- Product Type: biologics
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: An FDA inspection of HemaCare Corp, a blood donor center in Los Angeles, CA, revealed significant deficiencies. Observations included inadequate training and experience for personnel, specifically the acting Donor Center Manager, and a lack of regular calibration for blood collection equipment. Additionally, the firm's standard operating procedures for autologous donations were found to be inadequate.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/yvonne-c-wilkes/44e7b094-d09a-48f0-a0ee-f1a6506f935a)

Company: https://www.globalkeysolutions.net/companies/hemacare-corp/9680df30-2873-4af7-ad2c-81f6aae55609

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6